Evidence map›Paper›PMID 27106006›Full record

SynthesisThe Kaohsiung journal of medical sciences2016

Fluoroquinolone prophylaxis in preventing BK polyomavirus infection after renal transplant: A systematic review and meta-analysis.

Tu-Run Song, Zheng-Sheng Rao, Yang Qiu, Jin-Peng Liu, Zhong-Li Huang, Xian-Ding Wang, Tao Lin

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The Kaohsiung journal of medical sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Interventions for BK virus infection in kidney transplant recipients.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Pooled it
  3. Review
  4. BK viral infection: A review of management and treatment.World journal of transplantation · 2023
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Tu-Run SongDepartment of Urology, Urology Institute and Organ Transplantation Center, West China Hospital, Sichuan University, Sichuan, China.
Zheng-Sheng RaoDepartment of Urology, Urology Institute and Organ Transplantation Center, West China Hospital, Sichuan University, Sichuan, China.
Yang QiuDepartment of Urology, Urology Institute and Organ Transplantation Center, West China Hospital, Sichuan University, Sichuan, China.
Jin-Peng LiuDepartment of Urology, Urology Institute and Organ Transplantation Center, West China Hospital, Sichuan University, Sichuan, China.
Zhong-Li HuangDepartment of Urology, Urology Institute and Organ Transplantation Center, West China Hospital, Sichuan University, Sichuan, China.
Xian-Ding WangDepartment of Urology, Urology Institute and Organ Transplantation Center, West China Hospital, Sichuan University, Sichuan, China.
Tao LinDepartment of Urology, Urology Institute and Organ Transplantation Center, West China Hospital, Sichuan University, Sichuan, China. Electronic address: Kidney5@163.com.
Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies regarding the prevention of BK viremia following renal transplantation with fluoroquinolone have yielded conflicting results. The purpose of this systematic review was to examine the evidence regarding the efficacy of fluoroquinolone in preventing BK polyomavirus infection following renal transplantation. We searched PubMed, Embase, and the Cochrane Central Register of Controlled Trials for research articles published prior to January 2015 using keywords such as "fluoroquinolone," "BK viremia," and "renal transplantation." We extracted all types of study published in English. The primary outcome was BK viremia and viruria at 1 year post-transplantation. Secondary outcomes were BK virus-associated nephropathy (BKVN), graft failure, and fluoroquinolone-resistant infection. We identified eight trials, including a total of 1477 participants with a mean duration of fluoroquinolone prophylaxis of >1 month. At 1 year, fluoroquinolone prophylaxis was not associated with a decreased incidence of BK viremia [risk ratio (RR), 0.84; 95% confidence interval (95% CI), 0.58-1.20). No significant differences in BKVN (RR, 0.88; 95% CI, 0.37-2.11), risk of graft failure due to BKVN (RR, 0.68; 95% CI, 0.29-1.59), or fluoroquinolone-resistant infection (RR, 1.08; 95% CI, 0.64-1.83) were observed between the fluoroquinolone prophylaxis and control groups. The results of this study suggest that fluoroquinolone is ineffective in preventing BK polyomavirus infection following renal transplantation.

Indexed as

BK VirusFluoroquinolonesGenetic HeterogeneityGraft RejectionHumansKidney TransplantationPolyomavirus InfectionsPublication BiasTreatment OutcomeFluoroquinolonesBK polyomavirusFluoroquinolonesKidney transplantation

Identifiers

PMID27106006
PMCPMC11916583
OpenAlexW2283433215

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.